ORIC Pharmaceuticals Grants 14,800 Stock Options, 2,400 Restricted Stock Units to New Employee

By Public Technologies
  • ORIC Pharmaceuticals granted 14,800 non-qualified stock options and 2,400 restricted stock units to one new non-executive employee on Nov. 2, 2026.
  • The employee joined in October 2026; the awards fall under the 2022 Inducement Equity Incentive Plan.
  • Options vest 25% on the grant date’s first anniversary, with 1/36 of the remaining shares vesting monthly thereafter.
  • Restricted stock units vest in equal thirds on the grant date’s first three anniversaries.
  • Vesting requires continued employment or service through each applicable vesting date.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Oric Pharmaceuticals Inc published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202611061630PRIMZONEFULLFEED9868845) on November 06, 2026, and is solely responsible for the information contained therein.

Capital Com is an execution-only service provider. The present material must be regarded as marketing communication and should not be interpreted as investment research or investment advice. Any opinion that may be provided on this page does not constitute a recommendation by Capital Com or its agents. We do not make any representations or warranty on the accuracy or completeness of the information that is provided on this page. If you rely on the information on this page, then you do so entirely at your own risk